Track the 메타케어 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 메타케어 has recorded 2 reports. Market capitalisation: €21.5bn. The latest transaction was disclosed on 7 May 2026 (Sale). Among the most active insiders: 메타랩스. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
MetaCare是一家在医疗保健和制药领域运营的公司,在XKRX市场上市。它专注于开发创新解决方案以提升医疗保健服务。